News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
164,980 Results
Type
Article (6839)
Company Profile (123)
Press Release (158018)
Section
Business (53810)
Career Advice (374)
Deals (9752)
Drug Delivery (28)
Drug Development (31944)
Employer Resources (68)
FDA (2724)
Job Trends (4125)
News (96451)
Policy (6752)
Tag
Academia (262)
Africa (170)
Alliances (12178)
Alzheimer's disease (340)
Approvals (2708)
Artificial intelligence (33)
Asia (13148)
Australia (1424)
Bankruptcy (60)
Best Places to Work (3123)
Biotechnology (82)
C2C Services and Suppliers (2778)
California (824)
Canada (278)
Cancer (199)
Career advice (317)
Cell therapy (46)
China (100)
Clinical research (26160)
Collaboration (61)
Colorado (28)
Compensation (65)
Connecticut (32)
COVID-19 (635)
Data (194)
Delaware (22)
Diabetes (27)
Diagnostics (584)
Earnings (22138)
Employer resources (59)
Europe (23842)
Events (32475)
Executive appointments (87)
FDA (2804)
Florida (82)
Funding (47)
Gene therapy (24)
GLP-1 (195)
Government (700)
Healthcare (2290)
Hotbed/Location (119476)
Illinois (35)
Indiana (42)
Infectious disease (643)
Inflammatory bowel disease (36)
Interviews (72)
IPO (5688)
Job creations (1020)
Job search strategy (271)
Kansas (44)
Layoffs (112)
Legal (901)
Lung cancer (41)
Manufacturing (49)
Maryland (120)
Massachusetts (727)
Medical device (457)
Medtech (458)
Mergers & acquisitions (4107)
Metabolic disorders (91)
Michigan (26)
Minnesota (39)
Neuroscience (399)
New Jersey (310)
New York (335)
NextGen Class of 2024 (989)
Non-profit (242)
North Carolina (241)
Northern California (376)
Now hiring (22)
Obesity (47)
Ohio (42)
Opinion (69)
Patents (26)
Pennsylvania (192)
People (16768)
Pharmaceutical (39)
Phase I (7884)
Phase II (12051)
Phase III (8820)
Pipeline (67)
Podcasts (31)
Policy (33)
Postmarket research (511)
Preclinical (2950)
Radiopharmaceuticals (104)
Rare diseases (41)
Real estate (1195)
Recruiting (27)
Regulatory (5435)
Research institute (287)
Resumes & cover letters (44)
South America (218)
Southern California (344)
Startups (959)
Texas (86)
United States (3343)
Vaccines (98)
Washington State (66)
Weight loss (29)
Date
Today (22)
Last 7 days (207)
Last 30 days (931)
Last 365 days (13275)
2024 (9897)
2023 (14382)
2022 (16290)
2021 (17907)
2020 (15275)
2019 (10056)
2018 (7218)
2017 (8974)
2016 (7369)
2015 (9363)
2014 (7128)
2013 (5128)
2012 (4952)
2011 (4878)
2010 (4829)
164,980 Results for "cue biopharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Cue Biopharma Presents Updated Data from Phase 1 Trial of CUE-101 in Recurrent/Metastatic HPV+ Head and Neck Cancer at the 2024 ASCO Annual Meeting
Cue Biopharma today announced updated data from its ongoing Phase 1 trial evaluating its lead oncology asset from the CUE-100 series of biologics, CUE-101.
June 4, 2024
·
9 min read
Press Releases
Cue Biopharma Announces Proposed Public Offering
September 27, 2024
·
4 min read
Genetown
Cue Biopharma to Present at Two Upcoming Investor Healthcare Conferences in June 2024
Cue Biopharma, Inc. today announced that it will participate in two investor conferences this June, the Jefferies Global Healthcare Conference, to be held in New York, NY, June 4-6 and the Oppenheimer Novel Targets and Immunology Summit, to be held in New York, NY on June 24.
June 3, 2024
·
2 min read
Press Releases
Cue Biopharma Announces Pricing of $12.0 Million Public Offering
September 27, 2024
·
5 min read
Genetown
Cue Biopharma to Participate in Fireside Chat at The Citizens JMP Life Sciences Conference
Cue Biopharma, Inc. announced that it will take part in a fireside chat at The Citizens JMP Life Sciences Conference being held in New York, May 13-14, 2024.
May 7, 2024
·
1 min read
Genetown
Cue Biopharma to Present at the 20th Annual PEGS Boston Summit
Cue Biopharma, Inc. announced today that it will deliver two poster presentations at the 20th PEGS Boston Summit, the Essential Protein and Antibody Engineering Summit, being held May 13-17, 2024 in Boston, MA and virtually.
May 8, 2024
·
2 min read
Business
Cue Biopharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate disease-specific T cells, provided a business and financial update for the first quarter 2024.
May 9, 2024
·
7 min read
Genetown
Cue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured at the 2024 Multi-disciplinary Head and Neck Cancers Symposium
Cue Biopharma, Inc. announced today that the company’s lead clinical asset, CUE-101, will be featured in a presentation at the 2024 Multi-disciplinary Head and Neck Cancers Symposium given by Alexander Dimitrios Colevas, M.D., a principal investigator at Stanford University participating in the CUE-101 clinical trial.
February 29, 2024
·
3 min read
Press Releases
Cue Biopharma to Present at The Promise of Interleukin-2 Therapy Conference
September 3, 2024
·
5 min read
Genetown
Cue Biopharma to Present at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Cue Biopharma, Inc. announced that it will present an oral abstract and poster at the American Society of Clinical Oncology Annual Meeting, taking place May 31 – June 4, 2024 in Chicago, IL.
April 24, 2024
·
2 min read
1 of 16,498
Next
